DossierENTITY

impurity issue

Coverage of impurity issue in the Nexus archive.

Earliest in view: Jul 30 · 07:34 UTCMost recent: Jul 30 · 07:34 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSJul 30 · 07:34 UTCBLOOMBERG
Dr. Reddy’s Sees Weight-Loss Drug Boosting Growth After Setback
Dr. Reddy’s Laboratories expects its generic anti-obesity drug to boost growth in the six months through March after resolving an impurity issue with the key ingredient and resuming supply in early November.